-
1 Comment
Hydrix Limited is currently in a long term downtrend where the price is trading 30.0% below its 200 day moving average.
From a valuation standpoint, the stock is 97.1% cheaper than other stocks from the Technology sector with a price to sales ratio of 2.1.
Hydrix Limited's total revenue sank by 54.4% to $4M since the same quarter in the previous year.
Its net income has dropped by 187.7% to $-5M since the same quarter in the previous year.
Finally, its free cash flow fell by 34.7% to $-397K since the same quarter in the previous year.
Based on the above factors, Hydrix Limited gets an overall score of 1/5.
| ISIN | AU0000028979 |
|---|---|
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Exchange | AU |
| CurrencyCode | AUD |
| Market Cap | 4M |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | 0.58 |
| Dividend Yield | None |
Hydrix Limited, together with its subsidiaries, operates as a product design and engineering company in Australia, Europe, North America, Singapore, and internationally. It operates in three segments: Hydrix Services, Hydrix Medical, and Hydrix Ventures. The company offers product design and development consulting services comprising systems engineering, software, electronics, mechanical, human factors, and industrial design services; and product consulting services consisting of engineering design, development, prototyping, manufacturer management, and certification process management services. It also distributes cardiovascular products comprising Guardian, a heart attack warning system; and Implicity, a cloud-based AI-driven remote cardiac patient monitoring and data management software. In addition, the company invests in early stage medical technology (medtech) companies. It serves the cardiovascular, medtech, defence, and industrial industries. The company was formerly known as Panorama Synergy Limited and changed its name to Hydrix Limited in November 2018. Hydrix Limited was incorporated in 1993 and is based in Mulgrave, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for HYD.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026